Education
About Us
Working with TipRanks
Follow Us
Immunocore Holdings (IMCR)
NASDAQ:IMCR
IMCR Analyst Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IMCR Stock 12 Month Forecast
Average Price Target
$66.80
▲(136.29% Upside)
| Highest Price Target$100.00 | Average Price Target$66.80 | Lowest Price Target$35.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
Reiterated
03/12/25
BTIG
Reiterated
03/11/25
H.C. Wainwright
Reiterated
03/11/25
Barclays
Reiterated
03/11/25
Leerink Partners
Reiterated
03/11/25
Needham
Reiterated
03/11/25
Morgan Stanley
Initiated
03/07/25
Goldman Sachs
Reiterated
02/28/25
Oppenheimer
Reiterated
02/27/25
TD Cowen
Reiterated
02/26/25
J.P. Morgan
―
Buy
―
Reiterated
01/12/25
Immunocore Holdings: Promising Pipeline and Strategic Advancements Position for Positive Outlook
Jefferies
$55→$45
Buy
59.18%
Upside
Reiterated
12/19/24
Immunocore Holdings (IMCR) PT Lowered to $45 at JefferiesJefferies analyst Michael Yee lowered the price target on Immunocore Holdings (NASDAQ: IMCR) to $45.00 (from $55.00) while maintaining a Buy rating.
Robert W. Baird
$84
Buy
197.13%
Upside
Reiterated
11/06/24
Immunocore Holdings: Strategic Advancements and Financial Stability Support Buy Rating
UBS
$24
Sell
-15.10%
Downside
Initiated
10/24/24
Immunocore initiated with a Sell at UBSImmunocore initiated with a Sell at UBS
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
Reiterated
03/12/25
BTIG
Reiterated
03/11/25
H.C. Wainwright
Reiterated
03/11/25
Barclays
Reiterated
03/11/25
Leerink Partners
Reiterated
03/11/25
Needham
Reiterated
03/11/25
Morgan Stanley
Initiated
03/07/25
Goldman Sachs
Reiterated
02/28/25
Oppenheimer
Reiterated
02/27/25
TD Cowen
Reiterated
02/26/25
J.P. Morgan
―
Buy
―
Reiterated
01/12/25
Immunocore Holdings: Promising Pipeline and Strategic Advancements Position for Positive Outlook
Jefferies
$55→$45
Buy
59.18%
Upside
Reiterated
12/19/24
Immunocore Holdings (IMCR) PT Lowered to $45 at JefferiesJefferies analyst Michael Yee lowered the price target on Immunocore Holdings (NASDAQ: IMCR) to $45.00 (from $55.00) while maintaining a Buy rating.
Robert W. Baird
$84
Buy
197.13%
Upside
Reiterated
11/06/24
Immunocore Holdings: Strategic Advancements and Financial Stability Support Buy Rating
UBS
$24
Sell
-15.10%
Downside
Initiated
10/24/24
Immunocore initiated with a Sell at UBSImmunocore initiated with a Sell at UBS
Best Analysts Covering Immunocore Holdings
Which Analyst Should I Follow If I Want to Buy IMCR and Sell After:
1 Month
xxx
Success Rate
9/25 ratings generated profit
Average Return
+0.83%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 36.00% of your transactions generating a profit, with an average return of +0.83% per trade.
3 Months
xxx
Success Rate
13/25 ratings generated profit
Average Return
+8.83%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.00% of your transactions generating a profit, with an average return of +8.83% per trade.
1 Year
Success Rate
5/12 ratings generated profit
Average Return
+4.72%
reiterated a buy rating 2 months ago
Copying Jessica Fye's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.72% per trade.
2 Years
xxx
Success Rate
4/12 ratings generated profit
Average Return
-4.35%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -4.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IMCR Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
20
14
14
13
17
Buy
0
0
0
0
1
Hold
2
3
2
3
4
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
23
18
16
16
22
Each month's total comprises the sum of three months' worth of ratings.
IMCR Financial Forecast
IMCR Stock Forecast FAQ
What is IMCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Immunocore Holdings’s 12-month average price target is $66.80.
What is IMCR’s upside potential, based on the analysts’ average price target?
Immunocore Holdings has 136.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IMCR a Buy, Sell or Hold?
Immunocore Holdings has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
What is Immunocore Holdings’s price target?
The average price target for Immunocore Holdings is $66.80. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $100.00 ,the lowest forecast is $35.00. The average price target represents 136.29% Increase from the current price of $28.27.
The highest analyst price target is $100.00 ,the lowest forecast is $35.00. The average price target represents 136.29% Increase from the current price of $28.27.
What do analysts say about Immunocore Holdings?
Immunocore Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of IMCR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.